• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

50.47 +1.70 (+3.48%)
Streaming Delayed Price Updated: 12:14 PM EDT, Jul 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,711,589
Open 49.82
Bid (Size) 50.46 (1,000)
Ask (Size) 50.47 (100)
Prev. Close 48.77
Today's Range 49.78 - 50.90
52wk Range 35.12 - 71.80
Shares Outstanding N/A
Dividend Yield 5.05%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
2 Top Growth Stocks to Buy Right Now Without Hesitation ↗
June 29, 2026
These stocks are no-brainer buys. 
Via The Motley Fool
Topics Economy
News headline image
Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could ↗
June 29, 2026
These stocks are better bets to skyrocket than the much-hyped rocket stock. 
Via The Motley Fool

Performance

YTD
-3.7%
-3.7%
1 Month
+14.5%
+14.5%
3 Month
+38.3%
+38.3%
6 Month
-0.8%
-0.8%
1 Year
-27.7%
-27.7%

More News

Read More
News headline image
Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now ↗
June 27, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Better Buy in the Obesity Drug Race: Novo Nordisk or Eli Lilly? ↗
June 26, 2026
Via The Motley Fool
News headline image
An Analyst Just Declared Eli Lilly the "Clear Winner" of an American Diabetes Association Conference Focused on Weight-Loss Drugs. Novo's Chief Scientist Disagrees. Who's Right? ↗
June 25, 2026
Via The Motley Fool
News headline image
The Artificial Intelligence Opportunity Beyond Big Tech: 3 Healthcare Stocks to Watch ↗
June 25, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
2 Underrated Weight Loss Stocks to Buy and Hold ↗
June 23, 2026
Via The Motley Fool
News headline image
Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk ↗
June 22, 2026
Via The Motley Fool
News headline image
Novo Nordisk's Wegovy Pill Just Hit 3 Million Prescriptions. Is Wall Street Missing Something With This Beaten-Down Stock? ↗
June 20, 2026
Via The Motley Fool
News headline image
3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend ↗
June 20, 2026
Via MarketBeat
Topics ETFs
News headline image
Eli Lilly vs. Novo Nordisk: Better Obesity Drug Stock? ↗
June 16, 2026
Via The Motley Fool
News headline image
3 Under-the-Radar Stocks to Buy and Hold for a Decade ↗
June 16, 2026
Via The Motley Fool
News headline image
3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow ↗
June 14, 2026
Via The Motley Fool
News headline image
Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About ↗
June 12, 2026
Via The Motley Fool
News headline image
Is Viking Therapeutics Stock Going to $100? ↗
June 12, 2026
Via The Motley Fool
News headline image
Why Pfizer Stock Popped Today ↗
June 11, 2026
Via The Motley Fool
News headline image
80% of Wegovy Pill Users Never Took a Weight Loss Drug Before. Does This Number Change the Entire Novo Nordisk Bear Case? ↗
June 07, 2026
Via The Motley Fool
News headline image
Novo's Wegovy Pill Isn't Just Beating Expectations -- It's Obliterating Them. Is the Beaten-Down Stock a Buy Now? ↗
June 06, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors ↗
June 05, 2026
Via The Motley Fool
News headline image
Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 Success ↗
June 04, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Forget Zepbound: Eli Lilly's Next Billion-Dollar Weight-Loss Drug May Be Even Better ↗
June 03, 2026
Via The Motley Fool
News headline image
Here's What I Think Is Really Going on With Novo Nordisk Stock ↗
June 03, 2026
Via The Motley Fool
News headline image
Bull vs. Bear: The Quick Take on Viking Therapeutics Stock ↗
June 03, 2026
Via The Motley Fool
News headline image
Eli Lilly Wins Back CVS Health, Reverting Novo's Advantage ↗
June 02, 2026
Via MarketBeat
News headline image
Viking Therapeutics' Q3 Catalyst That Could Turn Eli Lilly's and Novo Nordisk's Daily Weight Loss Pill Strategy Upside Down ↗
June 02, 2026
Via The Motley Fool

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 50.47
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 07/02/26 12:14 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap